11:15 Abstract: Ibrutinib with Low-Dose Dexamethasone in Relapsed or Relapsed/Refractory Multiple Myeloma HMP Education
18:46 What is the Best Treatment for Transplant-ineligible Myeloma Patients: 2, 3 or 4 drugs? HMP Education
17:26 Debate: To maintain or not to Maintain? Immunomodulators vs. PI - Yes (Proteasome Inhibitors) HMP Education
15:15 Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Brentuximab HMP Education
12:04 Debate: Best Second-line Approach to Induce Lymphoma Remission Prior to SCT? - Chemotherapy HMP Education
10:46 Debate: Value to Using Brentuximab vedotin Consolidation early after Auto-SCT in Hodgkin's? - Yes HMP Education
8:40 Debate: Value to Using Brentuximab vedotin Consolidation early after Auto-SCT in Hodgkin's? - No HMP Education
14:12 Abstract: Single-agent Ibrutinib 420mg Induces Durable Responses in Patients with CLL HMP Education
